Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022009123 - IL-2 VARIANTS

Publication Number WO/2022/009123
Publication Date 13.01.2022
International Application No. PCT/IB2021/056106
International Filing Date 07.07.2021
IPC
C07K 14/55 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
52Cytokines; Lymphokines; Interferons
54Interleukins (IL)
55IL-2
C12N 15/62 2006.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
62DNA sequences coding for fusion proteins
A61K 38/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
A61P 35/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants
  • EUTILEX CO., LTD. [KR]/[KR]
  • KWON, Byoung S. [KR]/[KR]
  • LEE, Seoung Hyun [KR]/[KR]
  • IM, Sun Woo [KR]/[KR]
  • CHOI, Jin Kyung [KR]/[KR]
  • SON, Hyun Tae [KR]/[KR]
  • LEE, Joong Won [KR]/[KR]
  • LEE, Hanna [KR]/[KR]
  • HWANG, Sunhee [KR]/[SA]
Inventors
  • KWON, Byoung S.
  • LEE, Seoung Hyun
  • IM, Sun Woo
  • CHOI, Jin Kyung
  • SON, Hyun Tae
  • LEE, Joong Won
  • LEE, Hanna
  • HWANG, Sunhee
Priority Data
63/050,06809.07.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) IL-2 VARIANTS
(FR) VARIANTS D'IL-2
Abstract
(EN) Provided are Interleukin (IL)-2 mutant proteins. The disclosure also provides nucleic acid sequences encoding the IL-2 mutant proteins.
(FR) L'invention concerne des protéines mutantes de l'interleukine (IL)-2. L'invention concerne également des séquences d'acides nucléiques codant pour les protéines mutantes d'IL-2
Latest bibliographic data on file with the International Bureau